Author:
Brinckmann Sarah,da Costa Kelly,van Gils Marit J,Hallengärd David,Klein Katja,Madeira Luisa,Mainetti Lara,Palma Paolo,Raue Katharina,Reinhart David,Reudelsterz Marc,Ruffin Nicolas,Seifried Janna,Schäfer Katrein,Sheik-Khalil Enas,Sköld Annette,Uchtenhagen Hannes,Vabret Nicolas,Ziglio Serena,Scarlatti Gabriella,Shattock Robin,Wahren Britta,Gotch Frances
Abstract
Abstract
Novel, exciting intervention strategies to prevent infection with HIV have been tested in the past year, and the field is rapidly evolving. EUROPRISE is a network of excellence sponsored by the European Commission and concerned with a wide range of activities including integrated developmental research on HIV vaccines and microbicides from discovery to early clinical trials. A central and timely theme of the network is the development of the unique concept of co-usage of vaccines and microbicides. This review, prepared by the PhD students of the network captures much of the research ongoing between the partners. The network is in its 5th year and involves over 50 institutions from 13 European countries together with 3 industrial partners; GSK, Novartis and Sanofi-Pasteur. EUROPRISE is involved in 31 separate world-wide trials of Vaccines and Microbicides including 6 in African countries (Tanzania, Mozambique, South Africa, Kenya, Malawi, Rwanda), and is directly supporting clinical trials including MABGEL, a gp140-hsp70 conjugate trial and HIVIS, vaccine trials in Europe and Africa.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献